Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp > ViaCyte CEO interview

<< Previous

Bullboard Posts

Next >>

Comment by BioTeckon Feb 03, 2022 1:02pm

241 Views

Post# 34393769

RE:RE:ViaCyte CEO interview

Spill needs to take a page from Shap-heros getting shite done book. Shap-hero already bombed his first clinical but woo'd the world anyways and now going in for round 2 with his new Extra McCRISPR cells. Spillup is still strictly focused on trying to serve up his Breakfast Burrito to any willing takers while patient 7 waits eagerly for his Egg McNuffin. Who will it be? Shap-hero, or Shap-zero? Will Spill finally spill the beans on the deal or will he just spill his coffee riding the SVA share price roller coaster? Stay tuned.

<< Previous

Bullboard Posts

Next >>

Investor’s corner: Solving chronic pain in dogs – A significant market opportunity